Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gemma Modinos

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Molecular Psychiatry|September 6, 2025
GABA<sub>A</sub> receptor availability in clinical high-risk and first-episode psychosis: a [<sup>11</sup>C]Ro15-4513 positron emission tomography studyPaulina B Lukow, Julia J Schubert, Mario Severino, et al.
The International Journal of Neuropsychopharmacology|December 12, 2025
Diazepam modulates anterior cingulate glutamate levels in people at clinical high-risk for psychosisAmanda Kiemes, Nicholas R Livingston, Paulina B Lukow, et al.
Schizophrenia (Heidelberg, Germany)|February 20, 2025
Association between Adverse Childhood Experiences and long-term outcomes in people at Clinical High-Risk for PsychosisStefania Tognin, Ana Catalan, Claudia Aymerich, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 24, 2024
Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosisNicholas R Livingston, Amanda Kiemes, Gabriel A Devenyi, et al.
Schizophrenia Research. Cognition|March 4, 2022
Verbal memory performance predicts remission and functional outcome in people at clinical high-risk for psychosisEmily P Hedges, Hannah Dickson, Stefania Tognin, et al.
Psychological Medicine|August 8, 2025
Diazepam modulates hippocampal CA1 functional connectivity in people at clinical high-risk for psychosisNicholas R Livingston, Amanda Kiemes, Owen O'Daly, et al.
Schizophrenia Bulletin Open|July 29, 2022
The Relationship Between Grey Matter Volume and Clinical and Functional Outcomes in People at Clinical High Risk for PsychosisStefania Tognin, Anja Richter, Matthew J Kempton, et al.
Schizophrenia Bulletin|December 23, 2025
Gray Matter Volume Abnormalities and the Association with the Trajectory of Symptoms and Functioning in Individuals at Clinical High Risk of PsychosisShuqing Si, Cheryl See, Emily P Hedges, et al.
Psychological Medicine|January 8, 2025
The effects of recent stressful life events on outcomes in individuals at clinical high risk for psychosis: results from the longitudinal EU-GEI high-risk studyCheryl R Z See, Shuqing Si, Emily Hedges, et al.
JAMA Psychiatry|November 14, 2019
Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for PsychosisGemma Modinos, Matthew J Kempton, Stefania Tognin, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Molecular Psychiatry|September 6, 2025
GABA<sub>A</sub> receptor availability in clinical high-risk and first-episode psychosis: a [<sup>11</sup>C]Ro15-4513 positron emission tomography studyPaulina B Lukow, Julia J Schubert, Mario Severino, et al.
The International Journal of Neuropsychopharmacology|December 12, 2025
Diazepam modulates anterior cingulate glutamate levels in people at clinical high-risk for psychosisAmanda Kiemes, Nicholas R Livingston, Paulina B Lukow, et al.
Schizophrenia (Heidelberg, Germany)|February 20, 2025
Association between Adverse Childhood Experiences and long-term outcomes in people at Clinical High-Risk for PsychosisStefania Tognin, Ana Catalan, Claudia Aymerich, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 24, 2024
Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosisNicholas R Livingston, Amanda Kiemes, Gabriel A Devenyi, et al.
Schizophrenia Research. Cognition|March 4, 2022
Verbal memory performance predicts remission and functional outcome in people at clinical high-risk for psychosisEmily P Hedges, Hannah Dickson, Stefania Tognin, et al.
Psychological Medicine|August 8, 2025
Diazepam modulates hippocampal CA1 functional connectivity in people at clinical high-risk for psychosisNicholas R Livingston, Amanda Kiemes, Owen O'Daly, et al.
Schizophrenia Bulletin Open|July 29, 2022
The Relationship Between Grey Matter Volume and Clinical and Functional Outcomes in People at Clinical High Risk for PsychosisStefania Tognin, Anja Richter, Matthew J Kempton, et al.
Schizophrenia Bulletin|December 23, 2025
Gray Matter Volume Abnormalities and the Association with the Trajectory of Symptoms and Functioning in Individuals at Clinical High Risk of PsychosisShuqing Si, Cheryl See, Emily P Hedges, et al.
Psychological Medicine|January 8, 2025
The effects of recent stressful life events on outcomes in individuals at clinical high risk for psychosis: results from the longitudinal EU-GEI high-risk studyCheryl R Z See, Shuqing Si, Emily Hedges, et al.
JAMA Psychiatry|November 14, 2019
Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for PsychosisGemma Modinos, Matthew J Kempton, Stefania Tognin, et al.
Pageof 9